| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
88,860,000 |
| Market
Cap: |
107.52(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.16 - $6.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aptose Biosciences is biotechnology company developing agents to treat medical needs in cancers, such as acute myeloid leukemia (AML), certain B-cell malignancies, high-risk myelodysplastic syndromes (MDS) and other hematologic malignancies. Co.'s product pipeline includes cancer drug candidates that exert potent activity as stand-alone agents and that improve the activities of other anticancer agents without causing overlapping toxicities. Co.'s clinical-stage programs include: CG-806, which is a mutation-agnostic FMS-like tyrosine kinase 3 / Bruton's tyrosine kinase inhibitor; and APTO-253, which is a small molecule MYC oncogene inhibitor.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
17,000 |
47,000 |
| Total Buy Value |
$0 |
$0 |
$53,380 |
$76,670 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
1 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Seizinger Bernd R. |
|
• • – |
2023-09-22 |
4 |
B |
$3.14 |
$53,380 |
D/D |
17,000 |
17,000 |
0.01 |
-35% |
|
| Bejar Rafael |
Sr. VP, Chief Medical Officer |
• – – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
110,000 |
|
- |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
513,252 |
|
- |
|
| Payne Fletcher |
SR VP & Chief Fin. Officer |
• – – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Ledru Philippe |
Chief Commercial Officer |
• – – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,500 |
|
- |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2022-09-19 |
4 |
B |
$0.68 |
$6,834 |
D/D |
10,000 |
363,252 |
2.81 |
9% |
|
| Payne Fletcher |
SR VP & Chief Fin. Officer |
• – – |
2022-09-19 |
4 |
B |
$0.68 |
$6,775 |
I/I |
10,000 |
10,000 |
1.99 |
9% |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2022-06-06 |
4 |
B |
$0.97 |
$9,681 |
D/D |
10,000 |
353,252 |
2.81 |
-41% |
|
| Ledru Philippe |
Chief Commercial OfficerOffice |
• – – |
2022-04-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500 |
|
-40% |
|
| Burger Denis R |
Director |
– • – |
2021-12-20 |
4 |
B |
$1.45 |
$14,490 |
D/D |
10,000 |
31,671 |
2.39 |
-20% |
|
| Platzer Erich |
Director |
– • – |
2021-12-16 |
4 |
B |
$1.37 |
$137,900 |
D/D |
100,000 |
505,000 |
2.39 |
-22% |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2021-12-16 |
4 |
B |
$1.52 |
$20,038 |
D/D |
13,183 |
343,252 |
2.81 |
-22% |
|
| Platzer Erich |
Director |
– • – |
2021-12-15 |
4 |
B |
$1.16 |
$316,340 |
D/D |
270,000 |
405,000 |
2.39 |
-3% |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2021-12-15 |
4 |
B |
$1.12 |
$19,961 |
D/D |
17,822 |
330,069 |
2.81 |
-3% |
|
| Bejar Rafael |
Sr. VP, Chief Medical Officer |
• – – |
2021-11-19 |
4 |
B |
$2.56 |
$25,600 |
D/D |
10,000 |
10,000 |
2.74 |
-41% |
|
| Burger Denis R |
Director |
– • – |
2021-11-19 |
4 |
OE |
$2.04 |
$11,051 |
D/D |
5,417 |
21,671 |
|
- |
|
| Drw Holdings, Llc |
10% Owner |
– – • |
2021-08-05 |
4 |
S |
$2.62 |
$157,200 |
I/I |
(60,000) |
8,888,275 |
|
57% |
|
| Drw Holdings, Llc |
10% Owner |
– – • |
2021-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,895,238 |
|
-24% |
|
| Drw Holdings, Llc |
10% Owner |
– – • |
2021-08-03 |
4 |
B |
$2.65 |
$151,406 |
I/I |
57,199 |
8,948,275 |
1.5 |
-24% |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2021-07-02 |
4 |
B |
$3.29 |
$19,998 |
D/D |
6,081 |
303,604 |
2.81 |
-27% |
|
| Whitehead Warren |
Director |
– • – |
2021-06-22 |
4 |
S |
$3.24 |
$31,104 |
D/D |
(9,600) |
15,000 |
|
35% |
|
| Whitehead Warren |
Director |
– • – |
2021-06-21 |
4 |
S |
$3.35 |
$51,590 |
D/D |
(15,400) |
24,600 |
|
39% |
|
| Whitehead Warren |
Director |
– • – |
2020-12-22 |
4 |
S |
$4.01 |
$81,200 |
D/D |
(20,000) |
40,000 |
|
-29% |
|
| Whitehead Warren |
Director |
– • – |
2020-12-22 |
4 |
OE |
$2.01 |
$40,200 |
D/D |
20,000 |
60,000 |
|
- |
|
| Rice William G. |
Chair, President & CEO |
• • – |
2020-07-10 |
4 |
S |
$6.05 |
$1,021,791 |
D/D |
(168,891) |
297,523 |
|
1% |
|
44 Records found
|
|
Page 1 of 2 |
|
|
0.01 (0.83%) 
